At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.

This Is Living With Cancer™ is a program designed for those who have been affected by cancer and those who love them. This program is available to anyone in the United States, regardless of age, income, race, location, cancer type or stage of disease. Anyone can use this program, whether they're currently on a Pfizer Oncology treatment or not.

We're Janssen Oncology. We're shaping the future of cancer treatment by providing transformative solutions that help alter the way cancers are treated, with the ultimate goal of identifying curative therapies. As a leader, we're committed to focusing on the wholistic needs of those who rely on our therapies to improve overall experience and outcomes that will change what a cancer diagnosis means. Together with our partners, we are focused on delivering solutions that make a positive impact on human health. This is our promise.

AutoNation, a provider of personalized transportation services, is driven by innovation and transformation. As one of America's most admired companies, AutoNation delivers a peerless customer experience recognized by data-driven consumer insight leaders, Reputation and J.D. Power. Through its bold leadership and brand affinity, the AutoNation Brand is synonymous with "DRVPNK" and "What Drives You, Drives Us." AutoNation has a singular focus on personalized transportation services that are easy, transparent, and customer-centric.